Salomon & Ludwin
VCYT icon

Salomon & Ludwin’s Veracyte VCYT Stock Holding History

Salomon & Ludwin’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40.5K Hold
880
– – ﹤0.01% 554
2026
Q2 		$52.7K Buy
880
+211
+32% +$8.85K ﹤0.01% 512
2026
Q1 		$21.6K Buy
669
+34
+5% +$1.26K ﹤0.01% 1029
2025
Q4 		$27.7K Sell
635
-1
-0.2% -$40 ﹤0.01% 657
2025
Q3 		$22.9K Buy
+636
New +$18.2K ﹤0.01% 735

Other funds holding VCYT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Salomon & Ludwin's VCYT Position: Q3 2026 in Review

Salomon & Ludwin held its Veracyte (VCYT) position steady in Q3 2026 at 880 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Salomon & Ludwin first reported a position in VCYT in Q3 2025 and has held it in 5 quarters since. The position peaked at $52.7K in Q2 2026. 300 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Salomon & Ludwin held 880 shares of Veracyte worth $40.5K as of Q3 2026.
  • Salomon & Ludwin left its Veracyte share count unchanged in Q3 2026.
  • Veracyte made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #554 holding.
  • Salomon & Ludwin first reported a position in Veracyte in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Veracyte position peaked at $52.7K in Q2 2026.
  • 300 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.